WANY
PBH icon

Wealthspire Advisors (New York)’s Prestige Consumer Healthcare PBH Stock Holding History

Wealthspire Advisors (New York)’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-94
Closed -$5.87K – 2328
2025
Q3 		$5.87K Buy
+94
New +$6.54K ﹤0.01% 2259

Other funds holding PBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wealthspire Advisors (New York)'s PBH Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of Prestige Consumer Healthcare (PBH) in Q4 2025, closing a stake of 94 shares — an estimated $5.87K sold.

Wealthspire Advisors (New York) first reported a position in PBH in Q3 2025 and held it in 1 quarter. The position peaked at $5.87K in Q3 2025. 354 funds tracked by Wall St. Rank hold PBH as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining Prestige Consumer Healthcare position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 94 Prestige Consumer Healthcare shares in Q4 2025, an estimated $5.87K.
  • Wealthspire Advisors (New York) first reported a position in Prestige Consumer Healthcare in Q3 2025 and held it in 1 quarter.
  • Wealthspire Advisors (New York)'s Prestige Consumer Healthcare position peaked at $5.87K in Q3 2025.
  • 354 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.